Bastyr University
26
2
2
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.5%
3 terminated/withdrawn out of 26 trials
86.4%
-0.1% vs industry average
0%
0 trials in Phase 3/4
5%
1 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
Environmental Toxicants Avoidance Study
Role: lead
Biofeedback for Psoriasis
Role: lead
The Canadian/US Integrative Oncology Study
Role: collaborator
Modifiable Variables in Parkinsonism (MVP)
Role: lead
Biological and Psychological Health Effect of Ramadan Study
Role: lead
Complementary and Alternative Care in Multiple Sclerosis
Role: lead
Addressing Microaggressions in Racially Charged Patient-provider Interactions: A Pilot Randomized Trial
Role: collaborator
Omega 7 Oil and Inflammatory Biomarker Study
Role: lead
Integrative Oncology Outcomes Study in Breast Cancer
Role: lead
Resveratrol and Midazolam Metabolism
Role: collaborator
Intranasal Glutathione in Parkinson's Disease
Role: lead
Evaluation of Coagulation in Multiple Sclerosis
Role: lead
Haptoglobin and Iron in Parkinson's Disease
Role: lead
Cannabis and Parkinson's Disease Tremor: A Natural History Study
Role: lead
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
Role: lead
Effects of Qigong on Type 2 Diabetic Patients
Role: lead
A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer
Role: lead
Complementary and Alternative Medicine Sauna Detoxification Study: Phase I
Role: lead
Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
Role: lead
Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study
Role: collaborator